Program Information
· Program

Bio & Medical Technology Development Program

· Directorate

Directorate for National Strategic R&D Programs

· Program objective

Secure and support the commercialization of core original technology directly related to human life and health in the fields of bio and state-of-the-art medicine, such as new drugs and stem cells

· Program details

Research areas: 11 areas, including the development of new drugs and next-generation medical technology


Eligibility: Researchers at universities, hospitals, and government-funded and private research institutes


Summary: Consists of 48 subcategory projects, including the development of new drug pipelines and next-generation medical equipment platform technology


Period: 2–10 years


Funding: KRW 100 million – 10 billion (USD 91 thousand – 9.09 million*) per project per year

* approximation based on exchange rate of 1 USD = 1,100 KRW

· Contact

LIM, Moo Keun; Biotechnology Team 2 (

· Project process
Jan., Mar. and May 2019
Feb., Apr. and Jul. 2019
Apr. Jun., and Sep. 2019
Jun., Aug., and Nov. 2019